Lung Transplant Research Program
The Lung Transplant Program is leading the effort to improve outcomes in life-threatening lung diseases.
Our research has contributed to recent advances in the understanding of advanced lung disease and lung transplantation including innovative medical and surgical treatments yielding improved quality-of-life and survival for patients.
These achievements have been most notable in the areas of emphysema, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, and cystic fibrosis, both before and after lung transplantation.
The Lung Transplant Program is currently investigating new methods of assessing patients with advanced lung disease in order to improve prioritization of lung transplant candidates. We are an investigational site for studies of new medical therapies for idiopathic pulmonary fibrosis.
Investigators at our medical center participated in the National Emphysema Treatment Trial and physicians at Columbia are currently performing lung volume reduction surgery for patients with emphysema.
|Attention: Special Seminar for All Lung Transplant Candidates|
|Lung transplant candidates and their families are asked to attend a special seminar regarding the NOVEL trial.|
Patients and families may attend one of the following sessions:
- Tuesday, August 2, 2011
2:30 - 3:30 pm
- Thursday, September 15, 2011
5:30 - 6:30 pm
- Wednesday, October 26, 2011
4:00 - 5:00 pm
Heart Centers Room 1 & 2
Milstein Hospital Building
177 Fort Washington Avenue
New York, NY 10032
For more information, please contact:
The Lung Transplant Program is also conducting several studies in collaboration with academic medical centers throughout the country.
These include studying genetic factors in lung donors and recipients that may determine the clinical course after transplantation.
We are investigating the determinants of good outcomes in the early post-transplant period, so that peri-operative outcomes may be optimized.
We are currently planning studies using measurements of gene expression in peripheral blood to diagnose acute lung rejection without invasive procedures. Studies of new post-transplant immunosuppression regimens are ongoing.
The Lung Transplant Program at Columbia University Medical Center is committed to improving the care of patients with lung disease before and after lung transplantation. Through research efforts such as these, we will continue to improve the outlook of patients with lung disease.
- Click here to view the Lung Transplant Program's current roster of clinical trials.
- Click here for a list of recent publications from members of the Lung Transplant Program at the Columbia University Medical Center